Ducol Organics And Colours Limited has received in-principle approval from the National Stock Exchange (NSE) to list 39,682 equity shares issued on a preferential basis. The approval, communicated on May 21, 2026, paves the way for these shares to be officially traded on the exchange following necessary confirmations from depositories.

Listing Approval Details

The NSE granted the approval for the listing of 39,682 equity shares of ₹10 each. These shares were allotted on a preferential issue basis to strategic investors. The shares bear distinctive numbers ranging from 16254277 to 16293958. The official communication from the exchange confirms that the shares will be listed and admitted to dealings upon receipt of confirmation from depositories, specifically NSDL and CDSL, regarding the credit of beneficiaries' accounts.

Regulatory Compliance

The company intimated the exchange regarding this development under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The application for the in-principle approval was processed via the NEAPS Portal, with the approval letter downloaded by the company on May 22, 2026.

The following table summarizes the key details of the approval:

The confirmation from the depositories is the final procedural step required before the shares commence trading on the NSE.

Ducol Organics and Colours Limited has disclosed the utilization of funds raised through its Initial Public Offering (IPO) for the quarter and year ended March 31, 2026. The statutory auditor's certificate confirms that the company raised a total of INR 31,51,20,000 via the public issue. As of the reporting date, the company has utilized INR 31,43,57,357 for the purposes outlined in the offer document.

Fund Utilization Details

The company reported that the balance unutilized amount of INR 7,62,643 is currently parked in a Fixed Deposit with NKGSB Bank. This placement was confirmed through bank statements and fixed deposit confirmations provided by the management. The utilization details were submitted to the National Stock Exchange of India Limited in compliance with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Half-Yearly Utilization

During the half-year period spanning from October 1, 2025, to March 31, 2026, the company utilized an aggregate amount of ₹22,39,19,170 from the IPO proceeds. This expenditure was allocated towards specific operational needs as detailed in the auditor's report.

Compliance Status

The statement of deviation or variation confirms that there has been no deviation in the use of funds raised compared to the original objects disclosed. The original allocation for the IPO proceeds was directed towards funding working capital requirements, general corporate purposes, and issue-related expenses. The audit committee and auditors have noted no deviations, and the monitoring agency was not applicable for this fund-raising exercise.